NCT05249621View on ClinicalTrials.gov

A Randomized Phase 1 of of MZE001 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

December 21, 2022

Study Completion Date

December 21, 2022

Conditions

Healthy

Interventions

DRUG

MZE001

Small molecule inhibitor of muscle glycogen synthase

DRUG

Placebo

Product containing excipients with no active ingredients

Trial Locations (1)

92780

Orange County Research Center, Tustin

Sponsors

Lead Sponsor

Maze Therapeutics

All Listed Sponsors

lead

Maze Therapeutics

INDUSTRY

NCT05249621 - A Randomized Phase 1 of of MZE001 in Healthy Volunteers | Biotech Hunter | Biotech Hunter